These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27471683)
21. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies. Azijli K; Stelloo E; Peters GJ; VAN DEN Eertwegh AJ Anticancer Res; 2014 Apr; 34(4):1493-505. PubMed ID: 24692676 [TBL] [Abstract][Full Text] [Related]
22. Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of Intralesional Da Gama Duarte J; Parakh S; Andrews MC; Woods K; Pasam A; Tutuka C; Ostrouska S; Blackburn JM; Behren A; Cebon J Front Immunol; 2018; 9():411. PubMed ID: 29552014 [TBL] [Abstract][Full Text] [Related]
23. Ipilimumab in the treatment of melanoma. Trinh VA; Hwu WJ Expert Opin Biol Ther; 2012 Jun; 12(6):773-82. PubMed ID: 22500861 [TBL] [Abstract][Full Text] [Related]
24. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884 [TBL] [Abstract][Full Text] [Related]
25. Current Status of Biological Therapies for the Treatment of Metastatic Melanoma. Tang T; Eldabaje R; Yang L Anticancer Res; 2016 Jul; 36(7):3229-41. PubMed ID: 27354579 [TBL] [Abstract][Full Text] [Related]
26. Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer. Graziani G; Tentori L; Navarra P Pharmacol Res; 2012 Jan; 65(1):9-22. PubMed ID: 21930211 [TBL] [Abstract][Full Text] [Related]
27. Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm. Khattak M; Fisher R; Turajlic S; Larkin J Ther Adv Med Oncol; 2013 Mar; 5(2):105-18. PubMed ID: 23450149 [TBL] [Abstract][Full Text] [Related]
28. Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab. Shahabi V; Whitney G; Hamid O; Schmidt H; Chasalow SD; Alaparthy S; Jackson JR Cancer Immunol Immunother; 2012 May; 61(5):733-7. PubMed ID: 22382362 [TBL] [Abstract][Full Text] [Related]